Zobrazeno 1 - 10
of 118
pro vyhledávání: '"Joseph Han"'
Autor:
Joseph Han, Shayan Owji, Aneesh Agarwal, Samir Kamat, Yen Luu, Adnan Mubasher, George Niedt, Chloe Ray, Hearn Jay Cho, Nicholas Gulati, Angela Lamb
Publikováno v:
Dermatopathology, Vol 10, Iss 3, Pp 226-230 (2023)
Bortezomib is the first proteasome inhibitor to treat a variety of malignancies and is currently part of the standard of care regimen for the initial treatment of patients with newly diagnosed multiple myeloma. While bortezomib is generally well tole
Externí odkaz:
https://doaj.org/article/9dffb2d0ed9c40bab6a55d4f4000b2f9
Autor:
Claire C Chen, Joseph Han, Carlene A Chinn, Jacob S Rounds, Xiang Li, Mehran Nikan, Marie Myszka, Liqi Tong, Luiz FM Passalacqua, Timothy Bredy, Marcelo A Wood, Andrej Luptak
Publikováno v:
eLife, Vol 13 (2024)
A self-cleaving ribozyme that maps to an intron of the cytoplasmic polyadenylation element-binding protein 3 (Cpeb3) gene is thought to play a role in human episodic memory, but the underlying mechanisms mediating this effect are not known. We tested
Externí odkaz:
https://doaj.org/article/6ce8568e8fd5416db4896c3fd04724ea
Autor:
Joseph Han, Aneesh Agarwal, Jade N. Young, Shayan Owji, Yen Luu, Dina Poplausky, Daniel Yassky, Yeriel Estrada, Jonathan Ungar, James G. Krueger, Nicholas Gulati
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-7 (2022)
Abstract Immune checkpoint inhibitors (ICIs) such as pembrolizumab have revolutionized the treatment of advanced melanoma, but many patients do not respond to ICIs alone, and thus there is need for additional treatment options. Topical immunomodulato
Externí odkaz:
https://doaj.org/article/d6e67a2fe1c6416fb2a6433de815f5be
Autor:
Joseph Han, BS, Joel Correa da Rosa, PhD, Shayan Owji, BS, Daniel Yassky, BSE, Yen Luu, BA, Yeriel Estrada, BS, Jonathan Ungar, MD, Andrew Ji, MD, James G. Krueger, MD, PhD, Nicholas Gulati, MD, PhD
Publikováno v:
JAAD International, Vol 9, Iss , Pp 65-68 (2022)
Externí odkaz:
https://doaj.org/article/5b63fe98858d4a4e8602cc261cd2ee86
Autor:
Joseph Han, BS, Peter Baek, BS, Dina Poplausky, BA, Aneesh Agarwal, BS, Jade N. Young, BS, Adnan Mubasher, MD, George Niedt, MD, Vaibhav Patel, MD, Nicholas Gulati, MD, PhD
Publikováno v:
JAAD Case Reports, Vol 33, Iss , Pp 33-35 (2023)
Externí odkaz:
https://doaj.org/article/bb341eb2df9048c9a52eb6818461f4c7
Autor:
Joseph Han, Hansen Tai, Dina Poplausky, Jade Young, Rishab Revankar, Peter Baek, Samantha Walsh, Nicholas Gulati
Publikováno v:
Skin Health and Disease, Vol 3, Iss 2, Pp n/a-n/a (2023)
Externí odkaz:
https://doaj.org/article/56a4c5a110a54cdbafacf5a2f9716b3f
Autor:
Joseph Han, BS, Gerardo Russo, MD, Scott Stratman, BS, Corinna E. Psomadakis, MBBS, Rachel Rigo, MD, Shayan Owji, BS, Yen Luu, BA, Adnan Mubasher, MD, Belen Rubio Gonzalez, MD, Jonathan Ungar, MD, Joanna Harp, MD, Cynthia Magro, MD, Benjamin Ungar, MD, Angela Lamb, MD, Nicholas Gulati, MD, PhD
Publikováno v:
JAAD Case Reports, Vol 24, Iss , Pp 101-104 (2022)
Externí odkaz:
https://doaj.org/article/85006adc04054de2af981a967a805d04
Autor:
Joseph Han, Joel Correa da Rosa, Aneesh Agarwal, Shayan Owji, Daniel Yassky, Yen Luu, Aatman Shah, Yeriel Estrada, Jonathan Ungar, Kavita Y. Sarin, James G. Krueger, Nicholas Gulati
Publikováno v:
JID Innovations, Vol 3, Iss 2, Pp 100179- (2023)
Diphencyprone (DPCP), a topical contact sensitizer, has shown efficacy in treating cutaneous melanoma metastases, including at times beyond the directly treated sites, but biomarkers indicative of treatment response have not been characterized. Thus,
Externí odkaz:
https://doaj.org/article/cedabaa3ff184ea18d627d5882d60109
Publikováno v:
JMIR Medical Education, Vol 8, Iss 4, p e38329 (2022)
The implications of the COVID-19 pandemic underscored the utility of home-based health care due in part to social distancing requirements, curtailment of elective hospital procedures, and patient apprehension of the health care setting. The pandemic
Externí odkaz:
https://doaj.org/article/7e5d42e136704075980e63a52f94413e
Publikováno v:
JMIR Dermatology, Vol 5, Iss 4, p e42345 (2022)
BackgroundProvider opt-out of accepting Medicare insurance is a nationally tracked metric by the Centers for Medicare & Medicaid Services (CMS) for all physicians, including dermatologists. Although this usually only consists of a small number of pro
Externí odkaz:
https://doaj.org/article/432b13f1bd25408493f90741fcfeb5d4